CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury

Part of paid clinical trials in Madison, Wisconsin.

Sponsor
University of Wisconsin, Madison
Study ID
NCT06840899
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Spinal Cord Injury
  • Supra-sacral Spinal Cord Injury
  • Urinary Incontinence

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • CBD — DRUG
    Twice daily 100mg cannabidiol (CBD)

Study Details

The goal of this feasibility study is to learn whether Cannabidiol (CBD) can improve urinary incontinence and other symptoms in people with recent spinal cord injury (SCI). Participants will take Epidiolex (purified CBD) for 90 days

Key Dates

Start date
Feb 13, 2026
Status verified
Mar 2026
Primary completion
May 31, 2027
Completion
May 31, 2027

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: CBD for urinary incontinence
    Participants will take CBD for 90 days

Primary Outcome Measure

Adherence to CBD (Epidiolex) regimen [ Time Frame: 90 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Wisconsin - MadisonMadisonWisconsin53705
Maria Flory
[email protected]
608-262-8652

Find similar trials in Madison, WI

By research site
University of Wisconsin - Madison· Madison, WI

Related Studies